What is hypoxia and why does it affect tissue health?
Oxygen is essential for cell function. Through breathing and blood circulation, it reaches the various organs and tissues, where it is used mainly by mitochondria to produce energy in the form of ATP. When oxygen availability becomes insufficient relative to cellular needs, this is known as hypoxia.
It is not simply a reduction in the oxygen breathed: hypoxia can result from different problems, affecting the entry of oxygen into the body, its transport in the blood, circulation to the tissues, or the cells' ability to use it.
It is useful to distinguish hypoxia from hypoxemia. The former indicates insufficient oxygen availability at the tissue level; the latter describes a reduction in the partial pressure of oxygen in arterial blood. The two conditions can be associated, but they are not synonyms: a tissue can receive little oxygen even when blood oxygenation is not severely compromised, for example in the presence of insufficient local blood flow.
The balance between oxygen supply and consumption is therefore essential for maintaining cellular homeostasis. When this balance is altered, cells activate adaptive responses that, if the condition persists, can be accompanied by metabolic changes, functional alterations, and inflammatory processes.
The different forms of hypoxia: they do not all have the same origin
To understand the phenomenon, it is important to distinguish the main types, because each may require different tests and interventions.
· Hypoxic hypoxia: occurs when the blood contains an insufficient amount of oxygen, for example in certain respiratory diseases or at high altitudes.
· Anemic hypoxia: depends on the blood's reduced capacity to transport oxygen, as can happen in anemia, when the availability of functional hemoglobin decreases.
· Circulatory hypoxia: is linked to insufficient blood supply. Even with adequate arterial oxygenation, reduced flow can prevent oxygen from reaching a given area in sufficient quantities.
· Histotoxic hypoxia: occurs when cells are unable to properly use the available oxygen, as can happen in certain poisonings.
· Hypoxia due to increased metabolic demand: occurs when the tissues' oxygen requirement exceeds the amount the body can provide. In this case, metabolic demand is higher than the available supply.
Hypoxia can affect a circumscribed area, constituting a local phenomenon, or involve the entire body. It can also present in an acute form, when it arises rapidly, or become chronic if the reduced oxygen availability persists over time.
When hypoxia becomes chronic: a condition that should not be underestimated
The body has adaptation systems that allow it to respond to reduced oxygen availability. If hypoxia is temporary and limited, cells can activate compensatory responses and recover their functionality when oxygen supply returns to adequate levels.
The situation changes when the oxygen deficiency is prolonged or recurs frequently. In these cases, adaptation mechanisms may not be sufficient to maintain tissue balance and may contribute to the development of metabolic and inflammatory alterations.
Among the body's responses to chronic hypoxia are:
· Increased red blood cell production: through erythropoietin (EPO), the kidney helps stimulate the production of erythrocytes, increasing the blood's oxygen-carrying capacity.
· Formation of new blood vessels: through angiogenesis processes, which can promote blood supply to the tissues.
· Adaptation of cellular metabolism: cells change the way they produce energy, trying to maintain essential functions even when oxygen is limited.
These responses are not necessarily pathological: they initially represent survival strategies. However, their persistent activation or activation in a context of concomitant alterations can be associated with cellular dysfunction and tissue damage.
Intermittent hypoxia and obstructive sleep apnea
A particularly interesting condition is intermittent hypoxia, in which oxygenation repeatedly decreases for limited periods, alternating with reoxygenation phases.
An important example is obstructive sleep apnea, a disorder characterized by recurrent episodes of narrowing or closure of the upper airways during nighttime rest. These events can cause temporary reductions in blood oxygenation, awakenings, and fragmented sleep.
The phenomenon does not only affect sleep quality. The repetition of hypoxia and reoxygenation phases can promote oxidative stress, inflammatory activation, alterations in endothelial function, and activation of the sympathetic nervous system. Over time, obstructive sleep apnea is associated with an increased risk of cardiovascular and metabolic complications.
Intense and habitual snoring, observed breathing pauses during sleep, awakenings with a feeling of suffocation, non-restorative sleep, and daytime sleepiness are signs that deserve medical evaluation. Diagnosis may require a sleep study, such as polysomnography or an appropriate home respiratory test.
How cells recognize oxygen deficiency: the HIF system
One of the main advances in understanding hypoxia has been the discovery of the molecular mechanisms through which cells perceive oxygen availability and modify their activity.
A central role is played by hypoxia-inducible factors, indicated by the acronym HIF (Hypoxia-Inducible Factors). These are transcription factors that regulate the expression of numerous genes involved in cellular adaptation.
Among these, HIF-1 is composed of two subunits: HIF-1α, whose stability depends on oxygen availability, and HIF-1β, which is more constantly present in the cell.
When oxygen is available in adequate quantities, certain enzymes called prolyl hydroxylases (PHD) modify HIF-1α through a hydroxylation process. This modification allows the VHL (von Hippel-Lindau) protein to recognize it and direct it toward degradation in the proteasomes. In this way, HIF-1α activity is kept under control.
When oxygen decreases, the activity of PHD enzymes is reduced. HIF-1α is no longer degraded with the same efficiency, accumulates, and reaches the cell nucleus, where it associates with HIF-1β.
The complex thus formed binds to specific DNA sequences, called hypoxia response elements (HRE), regulating the expression of genes involved in the cellular response.
Among the processes influenced by HIF, we find:
· the production of erythropoietin, which stimulates the formation of red blood cells;
· the production of VEGF, a factor that promotes the formation of new blood vessels;
· the activation of enzymes and transporters involved in glucose metabolism;
· the regulation of cell survival and adaptation;
· the modulation of various signals involved in the inflammatory response.
The HIF system, therefore, is not simply an indicator of oxygen deficiency: it is a true biological regulatory system, through which cells try to adapt to an environment that no longer guarantees the usual metabolic conditions.
The change in energy metabolism: from mitochondrial respiration to glycolysis
One of the most important consequences of hypoxia concerns energy production.
Under normal conditions, mitochondria use oxygen to support oxidative phosphorylation, a process that allows the production of large quantities of ATP, the main molecule used by cells to fuel their activities.
When oxygen becomes insufficient, the cell tries to compensate by increasing its reliance on glycolysis, a metabolic pathway that allows energy to be derived from glucose even under conditions of limited oxygen availability.
However, glycolysis produces a much lower amount of ATP compared to mitochondrial respiration. For this reason, the cell must modify its metabolism and increase the efficiency of the energy pathways still available.
HIF-1 contributes to this reprogramming by stimulating the expression of glucose transporters and glycolytic enzymes.
When the hypoxic condition is intense or prolonged, however, energy production can become insufficient relative to cellular needs. This can lead to alterations in ionic gradients across membranes, intracellular calcium accumulation, pH changes, and impairment of organelle functions.
The increase in lactate production and the modification of the intracellular acid-base balance represent further aspects of the metabolic response. It is not simply an accumulation of a waste substance, but a complex transformation of cellular metabolism.
If oxygen supply is promptly restored, some alterations can be reversible. If, instead, the damage persists, cellular dysfunction, loss of membrane integrity, and, in the most severe cases, cell death can occur.
Hypoxia and inflammation: an interaction that can amplify tissue damage
The relationship between hypoxia and inflammation represents one of the most important aspects for understanding the consequences of reduced oxygenation on health.
When cells perceive an oxygen deficiency, they activate HIF and other signaling pathways that contribute to the adaptive response. In certain conditions, these pathways can interact with the systems that regulate inflammation.
Among the key players in this interaction is NF-κB, a transcription factor involved in the regulation of numerous genes of the immune and inflammatory response.
In resting conditions, NF-κB is retained in the cytoplasm by an inhibitory protein called IκBα. When the cell receives certain activation signals, the IKK enzymatic complex can become active, modifying IκBα and promoting its degradation.
Once released from the inhibitor, NF-κB can enter the nucleus and activate the expression of genes involved in the production of inflammatory mediators, including several cytokines.
These include:
· TNF-α, involved in the regulation of the inflammatory response;
· IL-1β, an important mediator of immune activation;
· IL-6, involved in the systemic inflammatory response and the regulation of numerous metabolic processes.
HIF and NF-κB can mutually influence each other. Hypoxia can promote the activation of inflammatory pathways and, conversely, some inflammatory mediators can increase the expression or stability of HIF. This creates a signaling network in which the response to hypoxia and the inflammatory response can reinforce each other.
It is important to clarify that HIF does not always necessarily lead to an increase in inflammation: its activity depends on the cell type, the duration and intensity of hypoxia, and the biological context. In some situations, adaptive and protective responses prevail; in others, especially when the stimulus is persistent or intermittent, damage mechanisms may prevail.
When hypoxia affects adipose tissue: the link with insulin resistance
A particularly interesting example of the relationship between hypoxia and inflammation concerns adipose tissue.
Adipose tissue is not merely an energy store: it is a metabolically active organ capable of producing numerous molecules called adipokines, which participate in the regulation of metabolism, appetite, insulin sensitivity, and the inflammatory response.
In obesity, especially when adipocytes increase significantly in volume, an imbalance can occur between the metabolic needs of the tissue and the capacity of the capillary network to supply oxygen.
The resulting local hypoxia can contribute to the activation of HIF-1 and the alteration of adipokine and cytokine production.
In this context, pro-inflammatory signals and the recruitment of immune cells, including macrophages, may increase, contributing to the maintenance of a state of low-grade chronic inflammation.
These alterations can interfere with insulin signaling pathways, impairing the cells' ability to use glucose correctly. Insulin resistance can thus become part of a complex metabolic circuit in which adipose tissue dysfunction, hypoxia, and inflammation mutually influence each other.
The available evidence indicates a biologically plausible and documented link, but does not prove that hypoxia is the sole cause of insulin resistance in obesity.
Hypoxia, circulation, and cell damage: what happens when the phenomenon persists
Another context in which hypoxia takes on particular relevance is that of circulatory alterations.
When blood flow decreases, an organ or tissue may receive less oxygen and nutrients. If the reduction is significant, ischemia may develop, i.e., a condition of insufficient blood perfusion.
Ischemia can cause a reduction in ATP production, alterations in cell membranes, and organelle dysfunction. If blood flow is quickly restored, some of the alterations may be reversible. If, however, the deficit is severe or prolonged, the damage can become irreversible and lead to cell death.
The restoration of circulation, while essential for saving the tissue, can also generate a further inflammatory and oxidative response in certain circumstances. This is the phenomenon of ischemia-reperfusion injury, studied particularly in transplants and various cardiovascular conditions.
This clarifies why tissue oxygenation depends not only on the amount of oxygen present in the blood, but also on the efficiency of circulation, the distribution of blood flow, and the cells' ability to use the oxygen they receive.
How can a patient notice a possible alteration in oxygenation?
Hypoxia is not a diagnosis that can be formulated simply on the basis of tiredness, fatigue, or other general symptoms. The manifestations depend on the cause, severity, duration, and organ involved.
When there is reduced blood oxygenation, breathing difficulties, increased heart rate, headache, confusion, or a bluish discoloration of the lips and skin may occur. In chronic forms, some symptoms may be less evident and develop gradually.
It is important not to confuse these signs with a general feeling of low energy: tissue hypoxia can be present even without easily recognizable symptoms, and it cannot be ruled out simply because a person does not experience any discomfort.
The tests are chosen by the doctor based on the clinical suspicion and may include:
· Pulse oximetry: indirectly measures peripheral oxygen saturation (SpO₂). Itis useful, but does not directly measure the oxygen available in individual tissues and does not identify all forms of hypoxia.
· Arterial blood gas analysis: allows for the assessment of the partial pressure of oxygen in arterial blood, carbon dioxide, and acid-base balance.
· Blood tests: can help identify anemia and other alterations that interfere with oxygen transport.
· Cardiovascular and respiratory assessment: allows for a more detailed evaluation of any conditions that reduce blood supply or the efficiency of gas exchange.
· Sleep studies: are indicated when obstructive sleep apnea or another nocturnal respiratory alteration is suspected.
Severe or sudden breathing difficulties, chest pain, loss of consciousness, acute confusion, or bluish discoloration of the lips require urgent evaluation.
Prevention begins with identifying the cause
There is no single intervention valid for all forms of hypoxia. The strategy depends on the mechanism that caused the reduced availability of oxygen.
If the problem is respiratory, pulmonary function and gas exchange will need to be investigated. If anemia is present, its cause must be identified and corrected under medical supervision. If the origin is circulatory, it will be important to assess tissue perfusion and cardiovascular function. When obstructive sleep apnea is suspected, the nocturnal respiratory disorder must be addressed.
Lifestyle also plays a role in metabolic and cardiovascular health. Physical activity appropriate to one's condition, a balanced diet, weight control, abstaining from smoking, and attention to sleep quality contribute to supporting the body's well-being. However, they do not replace the treatment of a respiratory, cardiac, hematological, or vascular condition.
Integrative medicine can help consider the person in their complexity, relating metabolism, diet, physical activity, sleep quality, stress, and emotional conditions. This approach must not confuse general health support with the treatment of hypoxia: the priority always remains identifying and treating the cause.
Inflammation and cellular well-being: the rationale behind Moltitudo Lunae
Understanding the relationship between hypoxia and inflammation allows for a deeper exploration of a broader topic: the role of inflammatory and oxidative processes in maintaining tissue balance.
This is where the formulation rationale of Moltitudo Lunae fits in, a dietary supplement that combines bromelain, Boswellia serrata, and tetrahydrocurcuminoids. The formulation is aimed at supporting the normal physiological functions involved in the inflammatory response and protection from excessive oxidative stress.
The three ingredients have different characteristics and have been the subject of biological and clinical studies, although the strength of the evidence is not equal for all, and the results obtained with specific extracts cannot be automatically transferred to any formulation.
Bromelain
It is a set of proteolytic enzymes derived from the pineapple stem. It has been studied for its possible interactions with inflammatory mediators, enzymatic processes, and phenomena associated with edema. Some systematic reviews have found favorable results in certain painful contexts, but the quality of the evidence and the transferability of the results depend on the condition studied, the preparation, and the dosage.
Boswellia serrata
Boswellia resin contains boswellic acids, molecules studied for their ability to modulate certain biochemical pathways of inflammation, including those linked to 5-lipoxygenase. Clinical studies and systematic reviews have examined especially the possible role of standardized preparations in joint well-being. The results are promising in some studies, but are not uniform and do not demonstrate the efficacy of every extract or product.
Tetrahydrocurcuminoids
They are hydrogenated metabolites of curcumin. They have been studied for their biological properties, including possible interactions with the systems regulating oxidative stress and inflammation. It is important to distinguish the evidence obtained on curcumin from that specific to tetrahydrocurcuminoids: they are not identical molecules, and it is not correct to automatically attribute to one form all the properties studied in the other.
The rationale of the combination is therefore to combine ingredients with different biological activities, which affect certain mechanisms involved in the inflammatory response. Their presence does not mean that the product is able to improve oxygenation, correct hypoxia, or treat an ischemic condition.
Moltitudo Lunae is not a treatment for hypoxia, anemia, ischemia, or respiratory and cardiovascular diseases. Its eventual use as a supplement must be evaluated in compliance with the directions for use, individual conditions, and possible interactions with medications.
The message to remember
Hypoxia is a complex condition that involves the entire cellular balance. The reduction of available oxygen can alter energy production, activate the HIF and NF-κB systems, and contribute, in certain contexts, to the onset of an inflammatory response.
The relationship between hypoxia and inflammation is bidirectional: oxygen deficiency can promote inflammatory signals, and inflammation can further alter tissue function and their ability to adapt.
The protection of cellular health begins with knowledge of the mechanisms that regulate the body and the personalization of the health path: a central principle of the Moltitudo approach and its integrated view of the person.
The relationship between oxygen deficiency, cellular metabolism, and inflammation
Oxygen is essential for the proper functioning of cells. It participates in mitochondrial respiration, ATP production, and the maintenance of the energy balance necessary to support tissue metabolic activities.
When the availability of oxygen becomes insufficient compared to cellular needs, a condition defined as hypoxia develops. The causes can differ: reduced blood oxygenation, anemia, insufficient circulatory perfusion, or the tissues' inability to use oxygen correctly.
The biological response to hypoxia involves a particularly important regulatory system: the hypoxia-inducible factor HIF, especially in its HIF-1 form.
Under normal oxygen conditions, PHD proteins promote the hydroxylation of HIF-1α, making it recognizable by the VHL system and targeting it for proteasomal degradation. When oxygen levels decrease, this degradation slows down. HIF-1α accumulates, binds to HIF-1β, and enters the cell nucleus, where it regulates the expression of numerous genes.
These include genes involved in the production of erythropoietin, the formation of new blood vessels through VEGF, and the reprogramming of energy metabolism.
The cell thus seeks to adapt to reduced oxygen availability by increasing glucose utilization through glycolysis and modifying its mitochondrial metabolism.
However, this adaptation is not always sufficient to maintain homeostasis.
When hypoxia persists, alterations in redox balance, metabolite accumulation, changes in intracellular pH, and the activation of inflammatory signals may occur.
One of the most important links concerns the interaction between HIF-1 and NF-κB, a transcription factor that controls numerous genes involved in the inflammatory response.
Their interaction can contribute to maintaining a state of inflammatory activation, especially when the imbalance between oxygen supply and demand is associated with tissue damage and microcirculatory alterations.
It is precisely in this context that it becomes interesting to also consider the role of oxidative stress and inflammatory balance in the nutritional support strategy.
MOLTITUDO® LUNAE: a vegan formulation for supporting inflammatory balance
MOLTITUDO LUNAE
Vegan formula
60 tablets of 1 g · 30 doses of 2 tablets
Food supplement based on three plant-derived ingredients, selected for their potential contribution to maintaining inflammatory balance and protecting against oxidative stress.
Official Moltitudo product page
MOLTITUDO® LUNAE is based on a formulation that combines three components with different biological characteristics:
· Bromelain extracted from pineapple stems.
· Standardized Boswellia serrata extract.
· Tetrahydrocurcuminoids derived from Curcuma longa.
The formulation philosophy favors plant-derived ingredients and an essential composition. The product is vegan, free from ingredients of animal origin, and contains no preservatives.
The nutritional objective is to support the physiological balance of inflammatory processes, tissue well-being, and the protection of cells against oxidative stress.
It is important to clarify that LUNAE does not increase blood oxygenation, does not correct hypoxia, and does not replace the necessary interventions to identify and treat its cause. Its rationale is based on a complementary level: nutritional support for the normal biological processes involved in inflammatory balance.
Dosage
It is recommended to take 1 tablet daily, orally, with water, preferably during or immediately after a meal.
In case of greater need, the product page allows for the possibility of taking 2 tablets daily, divided into two doses, one at lunch and one at dinner.
The maximum daily dose of 2 tablets provides:
|
Ingredient |
Quantity |
|
Pineapple stem extract, 2500 GDU |
1,000 mg |
|
Boswellia serrata extract, 65% boswellic acids |
500 mg |
|
Tetrahydrocurcuminoids |
140 mg |
The formulation also contains microcrystalline cellulose (E460) and vegetable magnesium stearate (E572).
The quantities indicated refer to the daily dose of two tablets. The dosage must comply with the instructions on the packaging and any assessments by a healthcare professional.
Chronic Inflammation and Drainage Supplement+1
The biological rationale of the three ingredients
Bromelain: support for fluid drainage and tissue function
Bromelain is a complex of proteolytic enzymes extracted from pineapple stems (Ananas comosus).
Its biological activity has been studied in relation to the modulation of inflammatory processes, vascular permeability, and the reabsorption of edema.
Among the mechanisms explored by research, we find:
· Modulation of some mediators of the arachidonic acid cascade.
· Interference with the production of prostaglandins and inflammatory cytokines.
· Modulation of leukocyte migration.
· Proteolytic activity and possible influence on interstitial fluid accumulation processes.
These mechanisms are interesting when considering the relationship between local inflammation, microcirculation, and tissue well-being.
In the presence of circulatory hypoxia, indeed, reduced perfusion can be associated with endothelial alterations, increased vascular permeability, and fluid accumulation in interstitial spaces.
Bromelain has been studied especially for its possible contribution to edema control and functional recovery after surgical procedures and trauma.
A systematic review and meta-analysis published in 2023 examined 54 studies, including 39 in the meta-analysis. The results highlighted a modest improvement in pain with oral bromelain compared to controls, while the evidence regarding other clinical areas was variable.
It is therefore reasonable to consider bromelain an interesting ingredient for supporting tissue well-being, without attributing to it the ability to correct an oxygenation deficit.
Scientific references:
· Rathnavelu V. et al. (2016). Potential role of bromelain in clinical and therapeutic applications. Biomedical Reports, 5(3), 283-288.
· Efficacy and safety of bromelain: A systematic review and meta-analysis (2023).
PubMed+1
Boswellia serrata: modulation of the 5-LOX pathway and inflammatory mediators
Boswellia serrata is a plant used to obtain a resin extract rich in boswellic acids.
Among these, 3-acetyl-11-keto-β-boswellic acid (AKBA) is particularly studied for its interaction with 5-lipoxygenase (5-LOX), an enzyme involved in the production of leukotrienes.
Leukotrienes are lipid mediators that participate in the inflammatory response and can influence vascular function and immune cell recruitment.
Boswellic acids have also been studied for their ability to modulate:
· NF-κB.
· TNF-α.
· Interleukin-1β.
· Interleukin-6.
· Some signals involved in the joint inflammatory response.
The link with hypoxia is particularly interesting because the hypoxic response can interact with NF-κB, promoting the activation of genes involved in inflammation.
Boswellia does not act directly on oxygen supply, but its constituents are being studied for the modulation of some inflammatory pathways that may be altered under conditions of tissue stress.
Clinical evidence: a 2020 meta-analysis, including seven randomized studies and 545 participants, found improvements in pain, stiffness, and joint function with Boswellia extracts compared to controls. However, a more recent review in 2024 highlighted significant heterogeneity among the studies, urging caution in interpreting the results.
PubMed+1
Scientific references:
· Ammon H.P. (2006). Boswellic acids in chronic inflammatory diseases. Planta Medica, 72(12), 1100-1116.
· Yu G. et al. (2020). Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complementary Medicine and Therapies, 20, 225. DOI: 10.1186/s12906-020-02985-6.
· Dalmonte T. et al. (2024). Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis. Phytotherapy Research, 38(12), 5672-5689. DOI: 10.1002/ptr.8336.
PRODUCT_ARTICLE
PLEASE NOTE: The information provided in the product sheets on this website is for informational and educational purposes only and does not constitute medical advice. The published content is not intended to replace the relationship with your doctor or any medical advice, diagnosis, or prescriptions. The information provided describes the ingredients and characteristics of food supplements, designed to support the body's balance and well-being as part of a healthy lifestyle. Food supplements are not medicines and must not be used to prevent, diagnose, treat, or alleviate diseases or medical conditions.
